Maternal PUFA ω-3 supplementation prevents neonatal lung injuries induced by hyperoxia in newborn rats

International Journal of Molecular Sciences

Volumn 16, Issue 9, 2015, Pages 22081-22093

  Sharma, Dyuti ^a,b   Nkembi, Armande Subayi ^a   Aubry, Estelle ^a,b   Houeijeh, Ali ^a,b   Butruille, Laura ^a   Houfflin Debarge, Véronique ^a,b   Besson, Rémi ^a,b   Deruelle, Philippe ^a,b   Storme, Laurent ^a,b  

^a UNIVERSITÉ DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Bronchopulmonary dysplasia; Diet; Prematurity; PUFA 3

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HYPEROXIA; LUNG INJURY; MATERNAL NUTRITION; MORPHOMETRICS; NEWBORN; NONHUMAN; OXYGEN TENT; PREGNANCY; RAT; SPECTROPHOTOMETRY; STERNOTOMY; ANIMAL; BRONCHOPULMONARY DYSPLASIA; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; LUNG; PATHOLOGY; WISTAR RAT;

ANIMALS; BRONCHOPULMONARY DYSPLASIA; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HYPEROXIA; LUNG; PREGNANCY; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RATS; RATS, WISTAR;

EID: 84941710666     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160922081     Document Type: Article

References (28)

1. Hilgendorff, A.; Reiss, I.; Ehrhardt, H.; Eickelberg, O.; Alvira, C.M. Chronic lung disease in the preterm infant. Am. J. Respir. Cell Mol. Biol. 2014, 50, 233-245.
2. Speer, C.P. Inflammation and bronchopulmonary dysplasia: A continuing story. Semin. Fetal Neonatal Med. 2006, 11, 354-362.
3. Bose, C.L.; Damman, C.E.; Laughon, M.M. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch. Dis. Child. Fetal Neonatal Ed. 2008, 93, 455-461.
4. Schneibel, K.R.; Fitzpatrick, A.M.; Ping, X.D.; Brown, L-A.S.; Gauthier, T.W. Inflammatory mediator patterns in tracheal aspirate and their association with bronchopulmonary dysplasia in very low birth weight neonates, J. Perinatol. 2013, 33, 383-387.
5. Vom Hove, M.; Prenzel, F.; Uhlig, H.H.; Robel-Tillig, E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: A case-control follow-up at school age. J. Pediatr. 2014, 164, 40-45.
6. Greenberg, J.A.; Bell, S.J.; van Ausdal, W. Omega-3 fatty acid supplementation during pregnancy. Rev. Obstet. Gynecol. 2008, 1, 162-169.
7. Schwartz, J.; Dube, K.; Alexy, U.; Kalhoff, H.; Kersting, M. PUFA and LC-PUFA intake during the first year of life: Can dietary practice achieve a guideline diet? Eur. J. Clin. Nutr. 2010, 64, 124-130.
8. Carlson, S.E.; Werkman, S.H.; Tolley, E.A. Effect of long-chain n-3 fatty acids supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am. J. Clin. Nutr. 1996, 63, 687-697.
9. Hanebutt, F.L.; Demmelmair, H.; Schiessl, B.; Larqué, E.; Koletzko, B. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin. Nutr. ESPEN 2008, 27, 685-693.
10. Agget, P.J.; Agostoni, C.; Axelsson, I.; de Curtis, M.; Goulet, O.; Hernell, O.; Koletzko, B.; Lafeber, H.N.; Michaelsen, K.F.; Puntis, J.W.L; et al. Feeding preterm infants after hospital discharge: A commentary by the ESPGHAN committee on nutrition. J. Pediatr. Gastroenterol. Nutr. 2006, 42, 596-603.
11. Zhang, P.; Lavoie, P.M.; Lacase-Masmonteil, T.; Rhainds, M.; Marc, I. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: A systematic review. Pediatrics 2014, 134, 120-134.
12. Larsen, B.M.K.; Goonewardene, L.A.; Joffre, A.R.; van Aerde, J.E.; Field, C.J.; Olstad, D.L.; Clandinin, M.T. Pre-treatment with an intravenous lipid emulsion containing fish oil (eicosapentaenoic and docosahexaenoic acid) decreases inflammatory markers after open-heart surgery in infants: A randomized, controlled trial. Clin. Nutr. 2012, 31, 322-329.
13. Larsen, B.M.K.; Field, C.J.; Leong, A.Y.; Goonewardene, L.A.; van Aerde, J.E.; Joffre, A.R.; Olstad, D.L.; Clandinin, M.T. Pretreatment with an intravenous lipid emulsion increases plasma eicosapentaenoic acid and downregulates leukotriene B4, procalcitonin, and lymphocte concentrations after open heart surgery in infants. J. Parenter. Enter. Nutr. 2015, 39, 171-179.
14. Rieger-Fackeldey, E.; Hentschel, R. Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models. J. Perinat. Med, 2008, 36, 442-447.
15. Berger, J.; Bhandari, V. Animal models of bronchopulmonary dysplasia. The term mouse models. Am. J. Physiol. Lung Cell Mol. Physiol. 2014, 307, 936-947.
16. De Visser, Y.P.; Walther, F.J.; el Laghmani, H.; van der Laarse, A.; Wagenaar, G.T.M. Apelin attenuates hyperoxic lung and heart injury in neonatal rats. Am. J. Respir. Crit. Care Med. 2010, 15, 1239-1250.
17. De Visser, Y.P.; Walther, F.J.; el Laghmani, H.; Steendijk, P.; Middeldorp, M.; van der Laarse, A.; Wagenaar, G.T. Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats. Am. J. Physiol. Lung Cell Mol. Physiol. 2012, 1, 56-67.
18. Houeijeh, A.; Aubry, E.; Coridon, H.; Montaigne, K.; Sfeir, R.; Deruelle, P.; Storme, L. Effects of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation. Crit. Care Med. 2011, 39, 1431-1438.
19. Singh, T.U.; Kathirvel, K.; Choudhury, S.; Garg, S.K.; Mishra, S.K. Eicosapentaenoic acid-induced endothelium-dependent and -independent relaxation of sheep pulmonary artery. Eur. J. Pharmacol. 2010, 636, 108-113.
20. Omura, M.; Kobayashi, S.; Mizukami, Y.; Mogami, K.; Todoroki-Ikeda, N.; Miyake, T.; Matsuzaki, M. Eicosapentaenoic acid (EPA) induces Ca2+-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett. 2001, 487, 361-366.
21. Alphonse, R.S.; Vadivel, A.; Coltan, L.; Eaton, F.; Barr, A.J.; Dyck, J.R.B.; Thebaud, B. Activation of Akt protects alveoli from neonatal oxygen-induced lung injury. Am. J. Respir. Cell Mol. Biol. 2011, 44, 146-154.
22. Porzionato, A.; Sfriso, M.M.; Mazzatenta, A.; Macchi, V.; de Caro, R.; di Giulio, C. Effects of hyperoxic exposure on signal transduction pathways in the lung. Respir. Physiol. Neurobiol. 2015, 209, 106-114.
23. Morin, C.; Hiram, R.; Rousseau, E.; Blier, P.U.; Fortin, S. Docosapentaenoic acid monoacylglyceride reduces inflammation and vascular remodeling in experimental pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 2014, 307, 574-586.
24. Martin, C.R.; Zaman, M.M.; Gilkey, C.; Salguero, M.V.; Hasturk, H.; Kantarci, A.; van Dyke, T.E.; Freedman, S.D. Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. PLoS ONE 2014, 9, e98773.
25. Béghin, L.; Storme, L.; Coopman, S.; Razka, T.; Gottrand, F. Parenteral nutrition with fish oil supplements is safe and seems to be effective in severe preterm neonates with respiratory distress syndrome. Acta Paediatr. 2015, doi:10.1111/apa.13091.
26. Lin, Y.J.; Markham, N.E.; Balasubramaniam, V.; Tang, J.R.; Maxey, A.; Kinsella, J.P.; Abman, S.H. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr. Res. 2005, 58, 22-29.
27. Tang, J.R.; Seedorf, G.J.; Muehlethaler V.; Walker, D.L.; Markham, N.E.; Balasubramaniam, V.; Abman, S.H. Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 6, 735-748.
28. Deruelle, P.; Balasubramaniam, V.; Kunig, A.M.; Seedorf, G.J.; Markham, N.E.; Abman, S.H. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats. Biol. Neonate 2006, 90, 135-144.